Waystar Enhances Financial Flexibility with Term Loan Repricing

Strong cash flow, ability to de-lever, and high lender demand drive favorable repricing terms

LEHI, Utah, and LOUISVILLE, Ky., Aug. 12, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the repricing of its first lien term loan due October 2029, securing more favorable terms as it advances its growth strategy. The transaction, which received substantial demand from new and existing lenders, reduces the interest rate on the term loan to adjusted SOFR +2.00%, a 25-basis-point reduction from prior terms. Waystar will also add $250 million of incremental term loans to the facility under the same terms, which is subject to the closing of the previously announced Iodine Software acquisition. The additional term loans will help fund a portion of the transformational acquisition of Iodine.

Read more at prnewswire.com